Ocrelizumab: A New Generation of anti‐CD20 mAb for Treatment of Multiple Sclerosis
Book chapter (July 2019)
The most recent citing publications are shown below. View all 34 publications that cite this research output on Dimensions.
Book chapter (July 2019)
Article in La Revue de Médecine Interne (August 2015)
Article in Clinical Rheumatology (October 2011)